These observations also highlight the importance of rapidly mounting strong CCCs/SARS-CoV-2 cross-reactive CD8+ T-cell responses, directed toward structural, non-structural, and accessory protein antigens, for protection against symptomatic and fatal Infections in unvaccinated COVID-19 patients. The gene discussed is CD8A; the disease is infection.